Leap Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Cypherpunk Technologies

13/05/2022 13:54

* Leap Therapeutics Inc  LPTX.OQ  reported a quarterly
adjusted
loss of 9 cents​​ per share for the quarter ended in March. The
mean expectation of five analysts for the quarter was for a loss
of 10 cents per share.
    * Reported revenue was zero​;  analysts expected $195.00
thousand. 
    * Leap Therapeutics Inc's reported EPS for the quarter was a
loss
of 9 cents​.
    * The mean earnings estimate of analysts had risen by
about 20% in
the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Leap Therapeutics Inc shares had fallen by 44.4% this
quarter and lost 70.0% so far this year.
    * The company reported a quarterly loss of $10.38 million.
    * Wall Street's median 12-month price target for Leap
Therapeutics
Inc is $5.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 13 at 12:54 p.m.  ​All
figures in US dollars unless otherwise stated